| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 26 |
| 1 | ALBUTEROL SULFATE | 23 |
| 2 | ETANERCEPT | 18 |
| 3 | LEVOTHYROXINE SODIUM | 15 |
| 4 | OMEPRAZOLE MAGNESIUM | 15 |
| 5 | PANTOPRAZOLE | 15 |
| 6 | PREGABALIN | 14 |
| 7 | ALBUTEROL | 12 |
| 8 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 12 |
| 9 | CELECOXIB | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETAMINOPHEN, DEXBROMPHENIRAMINE MALEATE | 1 | 0.0154 |
| 1 | DIMETICONE | 1 | 0.0035 |
| 2 | ACAMPROSATE CALCIUM | 1 | 0.0030 |
| 3 | RILZABRUTINIB | 1 | 0.0018 |
| 4 | PSYLLIUM HUSK | 2 | 0.0015 |
| 5 | BEVACIZUMAB-BVZR | 1 | 0.0014 |
| 6 | DACOMITINIB | 1 | 0.0013 |
| 7 | REVEFENACIN | 1 | 0.0011 |
| 8 | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | 1 | 0.0009 |
| 9 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 37 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 37 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 28 |
| 3 | Benzodiazepine [EPC] | 25 |
| 4 | Proton Pump Inhibitor [EPC] | 18 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 14 |
| 6 | Opioid Agonist [EPC] | 13 |
| 7 | Platinum-based Drug [EPC] | 13 |
| 8 | Vitamin B12 [EPC] | 12 |
| 9 | Vitamin C [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 1 | Phosphodiesterase 3 Inhibitor [EPC] | 3 | 0.0005 |
| 2 | Prostaglandin E1 Analog [EPC] | 4 | 0.0002 |
| 3 | Aminoglycoside Antibacterial [EPC] | 7 | 0.0002 |
| 4 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 5 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 6 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 7 | 0.0001 |
| 7 | Serotonin Reuptake Inhibitor [EPC] | 7 | 0.0001 |
| 8 | Cholinergic Muscarinic Antagonist [EPC] | 3 | 0.0001 |
| 9 | Histamine-2 Receptor Antagonist [EPC] | 10 | 0.0001 |